Synthesis, Antiproliferative Activity, and DNA Binding Studies of Nucleoamino Acid-Containing Pt(II) Complexes

Abstract

We here report our studies on the reaction with the platinum(II) ion of a nucleoamino acid constituted by the l-2,3-diaminopropanoic acid linked to the thymine nucleobase through a methylenecarbonyl linker. The obtained new platinum complexes, characterized by spectroscopic and mass spectrometric techniques, were envisaged to exploit synergistic effects due to the presence of both the platinum center and the nucleoamino acid moiety. The latter can be potentially useful to protect the complexes from early deactivation, as well as to facilitate their cell internalization. The biological activity of the complexes in terms of antiproliferative effects was evaluated in vitro on different cancer cell lines and healthy cells, showing the best results on human cervical adenocarcinoma (HeLa) cells along with good selectivity for cancer over normal cells. In contrast, the metal-free nucleoamino acid did not show any cytotoxicity on both normal and cancer cell lines. Finally, the ability of the novel Pt(II) complexes to bind various DNA model systems was investigated by circular dichroism (CD) spectroscopy and polyacrylamide gel electrophoresis analyses proving that the newly obtained compounds can potentially target DNA, similarly to other well-known anticancer Pt complexes, with a peculiar G-quadruplex vs. duplex selectivity.

Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems

“…MALDI-TOF MS measurements were performed on a TOF/TOF™ 5800 system using 2,5-dihydroxybenzoic acid (DHB) as a matrix and following previously optimized procedures [43,44].…”

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

“…To favour the efficient and selective brain release of drugs, NPs have also been functionalized with suitable nucleic acid-based aptamers, which are short oligonucleotides generally selected from a large random sequence pool by an iterative selection process, called Systematic Evolution of Ligands by EXponential enrichment (SELEX) [265][266][267]. Promising aptamers have been identified against several diseases [268][269][270][271][272][273][274][275][276][277], including neurodegenerative disorders, and thus explored as targeted ligands [278][279][280][281].…”

Novel arylplatinum complexes with 2,2′‐dimethyl‐4,4′‐bithiazole: Synthesis, characterization, single crystal structure determination, and investigation of CT‐DNA interaction

“…These compounds usually show different side effects; and so, the synthesis and design of new platinum complexes have received much more attention. [1][2][3][4][5][6] Several platinum complexes like cisplatin, oxaliplatin, and nedaplatin have been used in clinical treatments. However, researches have been continued to synthesize other platinum complexes as alternative chemicals with more effectiveness and fewer side effects.…”